PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway - Xiaoqing Li; Zhongxiang Jiang; Junfeng Li; Kun Yang; Jin He; Qianxi Deng; Shuman Xu; Zhihang Jiang; Fuqiang Liu; Zheng Jiang (Apoptosis, 2025)